Journal of Human Hypertension
IF
3.01
Papers
5,102
Papers 5,050
1 page of 505 pages (5,050 results)
Newest
#1Xin Wang (CAMS&PUMC: Chinese Academy of Medical Sciences & Peking Union Medical College)H-Index: 12
#2Guang Hao (JNU: Jinan University)H-Index: 8
Last. Runlin Gao (CAMS&PUMC: Chinese Academy of Medical Sciences & Peking Union Medical College)H-Index: 46
view all 13 authors...
Hypertension is a major health burden worldwide. However, there is limited data on the status of hypertension-mediated organ damage (HMOD) and established cardiovascular (CV) disease in Chinese hypertensive patients. The aim of this study is to determine the prevalence of HMOD and established CV disease in a nationally representative population in China. A stratified multistage random sampling method was used in the China Hypertension Survey and 21,243 participants aged 35 or older were eligible...
Source
#1Massimo Nardone (University of Guelph)H-Index: 7
#2Philip J. Millar (TGH: Toronto General Hospital)H-Index: 26
Source
#1Mario Funes Hernandez (SU: Stanford University)
#2Vivek Bhalla (SU: Stanford University)H-Index: 20
Last. Robert T. Isom (SU: Stanford University)H-Index: 2
view all 3 authors...
Source
#1Lihua Hu (PKU: Peking University)H-Index: 9
#2Chonglei BiH-Index: 2
Last. Jianping Li (PKU: Peking University)H-Index: 29
view all 17 authors...
Little information is available on the association between brachial-ankle pulse wave velocity (baPWV) and the risk of stroke in Chinese H-type hypertension patients. Therefore, our study aimed to assess this association between baseline baPWV and short-term risk of first stroke and to propose a cutoff value of baPWV that could predict near cerebrovascular events. A total of 9787 hypertension patients without preexisting stroke who underwent baPWV measurement were included. The primary end points...
Source
#1Anna Engell Holm (KUH: Copenhagen University Hospital)
#2Laura Cordeiro Gomes (USP: Universidade de São Paulo)H-Index: 1
Last. Philip Brainin (KUH: Copenhagen University Hospital)H-Index: 1
view all 13 authors...
Although infectious diseases have been associated with cardiovascular conditions, little is known about tropical disease burden and hypertension. We hypothesized that a history of tropical infections was associated with hypertension. We examined participants from outpatient clinics in the Amazon Basin who were interviewed about prior exposure to tropical diseases, including dengue, malaria hospitalization, and leishmaniasis. Hypertension was defined as a prior physician diagnosis of hypertension...
Source
#1Biplab K. Maiti (NITSKM: National Institute of Technology Sikkim)H-Index: 8
The recombinant soluble human angiotensin-converting enzyme 2 (rshACE2) is a promising therapy against SARS-CoV-2 infection, but it has some drawbacks that reduce the success of its clinical applications. The bioengineered ACE2 (Tag-sACE2 and probiotic-ACE2) as a way may overcome its therapeutic limitations against ongoing current pandemic.
Source
#1Reem Alsharari (LJMU: Liverpool John Moores University)H-Index: 1
#2Eduard Shantsila (LJMU: Liverpool John Moores University)
Last. Alena Shantsila (LJMU: Liverpool John Moores University)H-Index: 5
view all 4 authors...
Source
Source
#1Cormac Kennedy (TCD: Trinity College Dublin)H-Index: 6
Last. Michael J. Barry (TCD: Trinity College Dublin)H-Index: 111
view all 8 authors...
The recent STEP trials reported blood pressure reductions for obese patients treated with semaglutide. We analyzed a cohort of patients attending our hypertension clinic and found that 26% were severely or morbidly obese and morbidly obese patients frequently had resistant hypertension (41%). We suggest semaglutide may be an effective anti-hypertensive agent for obese patients with resistant hypertension and this hypothesis should be assessed in randomized clinical trials.
Source
#1Luca Faconti (KCL: King's College London)H-Index: 8
#2Franca Morselli (KCL: King's College London)H-Index: 2
Last. BritishH-Index: 1
view all 6 authors...
Source
12345678910
Top fields of study
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.